EUVIMEDEUVIMED entdecken
Crossref

Discovery and Crystallography Study of Novel Biphenyl Ether and Oxadiazole Thioether (Non-Arylmethylamine)-Based Small-Molecule PD-1/PD-L1 Inhibitors as Immunotherapeutic Agents

Jin Liu, Yao Cheng, Lin Yuan, Ting Liu, Yong Ruan, Yichang Ren, Ling Li, Sheng Jiang, Yibei Xiao, Jianjun Chen iD

Journal of Medicinal Chemistry · 28.09.2023 · 66 (18) · 13172-13188

DOI: 10.1021/acs.jmedchem.3c01141 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 07.09.2023. Verfasst von Jin Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Guangdong Provincial Key Laboratory of New Drug Screening, Southern Medical University, Guangzhou 510515, China. Hauptthemen laut MEDLINE: Oxadiazoles, Programmed Cell Death 1 Receptor, B7-H1 Antigen, Sulfides. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Southern Medical University, National Natural Science Foundation of China, Thousand Young Talents Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Current small-molecule PD-1/PD-L1 inhibitors are mainly based on the arylmethylamine/biphenyl core scaffold. Herein, we designed for the first time a series of non-arylmethylamine analogues (oxadiazole thioether derivatives) as small-molecule PD-1/PD-L1 inhibitors. Among them, compound LP23 exhibited the most potent PD-L1 inhibitory activity with an IC50 of 16.7 nM, 3.2-fold better than the lead BMS-202 (IC50 = 53.6 nM). The X-ray crystal structure of LP23 in complex with PD-L1 was solved at a resolution of 2.6 Å, which further confirmed the high binding affinity of LP23 to PD-L1. In the HepG2/Jurkat T cell co-culture model, LP23 effectively promoted HepG2 cell death by restoring the immune function of T cells. In addition, LP23 showed excellent in vivo antitumor efficacy (TGI = 88.6% at 30 mg/kg) and benign toxicity profiles in a B16-F10 tumor model by modulating PD-L1. In summary, LP23 represents the first non-arylmethylamine-based small-molecule PD-1/PD-L1 inhibitor worthy of further investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OxadiazolesProgrammed Cell Death 1 ReceptorB7-H1 AntigenSulfidesBiphenyl CompoundsImmune Checkpoint InhibitorsAntineoplastic AgentsHumansAnimalsMiceCrystallography, X-RayStructure-Activity RelationshipHep G2 CellsDrug DiscoveryJurkat CellsMice, Inbred C57BLImmunotherapy

Substanzen

OxadiazolesProgrammed Cell Death 1 ReceptorB7-H1 AntigenCD274 protein, humanSulfidesPDCD1 protein, humanBiphenyl CompoundsImmune Checkpoint InhibitorsAntineoplastic Agents

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences, Guangdong Provincial Key Laboratory of New Drug Screening, Southern Medical University, Guangzhou 510515, China.
  • Key Laboratory of Tropical Biological Resources of Ministry of Education and One Health Institute, School of Pharmaceutical Sciences, Hainan University, Haikou 570228, China.
  • State Key Laboratory of Natural Medicines and Department of Pharmacology, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China.
  • Chongqing Innovation Institute of China Pharmaceutical University, Chongqing 401135, China.
  • State Key Laboratory of Natural Medicines and Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China.

ORCID-Profile: Jianjun Chen

Förderung

  • Southern Medical University
  • National Natural Science Foundation of China
  • Thousand Young Talents Program of China

Zitieren

APA

Liu, J., Cheng, Y., Yuan, L., Liu, T., Ruan, Y., Ren, Y., Li, L., Jiang, S., Xiao, Y., & Chen, J. (2023). Discovery and Crystallography Study of Novel Biphenyl Ether and Oxadiazole Thioether (Non-Arylmethylamine)-Based Small-Molecule PD-1/PD-L1 Inhibitors as Immunotherapeutic Agents. Journal of Medicinal Chemistry, 66(18), 13172-13188. https://doi.org/10.1021/acs.jmedchem.3c01141

Vancouver

Liu J, Cheng Y, Yuan L, Liu T, Ruan Y, Ren Y, et al. Discovery and Crystallography Study of Novel Biphenyl Ether and Oxadiazole Thioether (Non-Arylmethylamine)-Based Small-Molecule PD-1/PD-L1 Inhibitors as Immunotherapeutic Agents. Journal of Medicinal Chemistry. 2023;66(18):13172-13188. doi:10.1021/acs.jmedchem.3c01141

BibTeX
@article{Liu2023,
  author = {Liu, Jin and Cheng, Yao and Yuan, Lin and Liu, Ting and Ruan, Yong and Ren, Yichang and Li, Ling and Jiang, Sheng and Xiao, Yibei and Chen, Jianjun},
  title = {Discovery and Crystallography Study of Novel Biphenyl Ether and Oxadiazole Thioether (Non-Arylmethylamine)-Based Small-Molecule PD-1/PD-L1 Inhibitors as Immunotherapeutic Agents},
  journal = {Journal of Medicinal Chemistry},
  year = {2023},
  volume = {66},
  number = {18},
  pages = {13172--13188},
  doi = {10.1021/acs.jmedchem.3c01141}
}
Kostenlos starten →